| |
| |
|
| Insider
Information: |
Skibsted Russell |
| Relationship: |
Chief Financial Office... |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
116,605 |
|
|
Indirect Shares
|
10,000 |
|
|
| Direct
Value |
$45,177 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
126,605 |
|
|
| Total
Value |
$45,177 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aeolus Pharmaceuticals Inc |
AOLS |
Chief Financial Officer |
2012-05-23 |
17,027 |
2011-05-18 |
10,000 |
Premium* |
|
|
Lineage Cell Therapeutics Ord Shs |
LCTX |
Chief Financial Officer |
2018-12-18 |
24,078 |
2017-08-23 |
0 |
Premium* |
|
|
Alimera Sciences Inc |
ALIM |
Chief Financial Office... |
2023-03-26 |
75,500 |
2023-01-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALIM |
Alimera Sciences Inc |
Chief Financial Officer & SVP |
• – – |
2023-03-26 |
4 |
A |
$0.00 |
$0 |
D/D |
58,000 |
75,500 |
0 |
- |
|
| ALIM |
Alimera Sciences Inc |
Chief Financial Officer & SVP |
• – – |
2023-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
17,500 |
17,500 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Chief Financial Officer |
• – – |
2018-12-18 |
4 |
D |
$1.03 |
$8,014 |
D/D |
(7,781) |
24,078 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Chief Financial Officer |
• – – |
2018-12-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,500 |
31,859 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Chief Financial Officer |
• – – |
2018-10-04 |
4 |
D |
$2.22 |
$8,638 |
D/D |
(3,891) |
9,359 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Chief Financial Officer |
• – – |
2018-10-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,250 |
13,250 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Chief Financial Officer |
• – – |
2017-08-23 |
4 |
B |
$2.64 |
$5,285 |
D/D |
2,000 |
2,000 |
2.74 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2012-05-23 |
4 |
B |
$0.24 |
$1,678 |
D/D |
7,027 |
17,027 |
2.66 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2011-05-18 |
4 |
B |
$0.43 |
$4,300 |
I/I |
10,000 |
10,000 |
1.91 |
- |
|
| AOLS |
Aeolus Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2011-05-18 |
4 |
B |
$0.41 |
$4,150 |
D/D |
10,000 |
10,000 |
2.66 |
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
